Santen Pharmaceutical Co (SNPHF) Q2 2024 Earnings Report
SNPHF Q2 2024 EPS Results
- Actual EPS
- $0.15
- Consensus EPS
- $0.14
- Beat/Miss
- Beat by +$0.01
- One Year Ago EPS
- $0.15
SNPHF Q2 2024 Revenue Results
- Actual Revenue
- $453.78M
- Expected Revenue
- $472.72M
- Beat/Miss
- Missed by -$18.94M
- YoY Revenue Growth
- -2.43%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 11/07/2024
- Time
- TBA
- Conference Call
- Thursday, November 7, 2024
SNPHF Upcoming Earnings
Santen Pharmaceutical Co's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
SNPHF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q2) | 0.20- | 0.15 | ― | ― |
| Aug 06, 2026 | 2026 (Q1) | 0.130.14 | 0.11 | 29.21% (+0.03) | |
| May 12, 2026 | 2025 (Q4) | 0.200.30 | 0.16 | 85.80% (+0.14) | |
| Feb 05, 2026 | 2025 (Q3) | 0.190.15 | 0.16 | -3.67% (-0.01) | |
| Nov 06, 2025 | 2025 (Q2) | 0.130.15 | 0.15 | 4.94% (+0.01) | |
| Aug 07, 2025 | 2025 (Q1) | 0.150.11 | 0.19 | -41.47% (-0.08) | |
| May 13, 2025 | 2024 (Q4) | 0.110.16 | 0.1 | 57.30% (+0.06) | |
| Feb 06, 2025 | 2024 (Q3) | 0.170.16 | 0.13 | 25.40% (+0.03) | |
| Nov 07, 2024 | 2024 (Q2) | 0.140.15 | 0.15 | -3.48% (-0.01) | |
| Aug 06, 2024 | 2024 (Q1) | 0.160.19 | 0.18 | 5.94% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
